Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

1-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases

US Patent 12312330 · Granted May 27, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →